For Dr. Sharifnia, the Bay Area has a great mix of cultures, diverse people, amazing food as well as the beauty of nature near a city, providing many opportunities to go hiking or spending the day in the park/beach, and she takes advantage of this! Outside of work, she loves to travel, hike, find the best bakeries, read, and spend time with family and friends.
Panid Sharifnia, MD, PhD
Dr. Sharifnia is a Board-Certified Adult Psychiatrist who is focused on treating Mood disorders, including Depression, Anxiety disorders, and PTSD.
More about Panid Sharifnia, MD, PhD
While initially planning a career in medical research, Dr. Panid Sharifnia was always interested in science and the science of the brain as it is complex on many levels. This eventually led her to psychiatry and clinical practice. Additionally, the emotional component of psychiatry, being able to connect with her patients, and helping them with issues in their lives were ultimately what drew her into psychiatry and helping patients. Dr. Sharifnia was naturally drawn to a place where she could make a real change in someone’s life.
Dr. Sharifnia works work collaboratively with her patients. She listens intently to her patients and what they hope to get out of their work together. She strives to have her patients keep an open mind regarding her recommendations and treatment plan and to help achieve their own, individual treatment goals. She wants each patient to feel comfortable talking about their conditions in order to provide different options that can make a real difference.
For Dr. Panid Sharifnia, Transcranial Magnetic Stimulation (TMS) and esketamine nasal spray provide treatment options for patients who may not be responding to medication alone. She also appreciates that TMS is still being researched for other uses. She first learned about interventional treatments such as TMS, esketamine, and ECT, in residency. After studying the promise of these treatments to help her patients, she knew she wanted to incorporate them into her practice.
Mindful Health’s clinicians such as Dr. Sharifnia ensure that each patient is met with an individual treatment plan that works for them. Being able to provide alternatives such as TMS and esketamine treatments allow for each individual to have options, and room to figure out what works best for them and their conditions. We’re determined to find the right solution for each patient, and have the alternatives and solution options to be able to do so.
Education & Experience
Dr. Sharifnia received her Bachelor of Arts in Molecular and Cell Biology: Biochemistry from the University of California, Berkeley. She was a member of Phi Beta Kappa and received a Biology Fellows Program Award as well as the Jesse Rabinowitz Prize in Biochemistry.
She received her medical degree as well as her Ph.D. from the University of San Diego. During her studies, she was awarded the Chateaubriand Fellowship, a grant awarded by the Embassy of France in the United States to support Ph.D. students to collaborate with research labs in France. She also received the NIH Predoctoral Grant T32 for funding in graduate studies.
She completed her Adult Psychiatry Residency at the University of California, San Francisco (UCSF).
During her residency, Dr. Sharifnia’s diverse experience included treating patients at Zuckerberg San Francisco General, where she provided psychiatric services to San Francisco’s underserved and chronically mentally ill population during short-term hospitalization. She gained expertise working with patients from diverse backgrounds (e.g., African American, Asian, Latinx, sexual and other minorities, etc.). She also spent time treating patients in the San Francisco County Jail’s inpatient psychiatry unit located at Zuckerberg San Francisco General and learning forensic psychiatry.
Dr. Sharifnia became Chief Resident for Adult Inpatient Services at Langley Porter Psychiatric Hospital and Clinics. While at Langley Porter Psychiatric Hospital and Clinic, she treated an extremely broad patient population, with ages ranging from late teens to over ninety and all socio-economic classes with a wide range of mental illnesses.
Datta V, Bourgeois J, Kaplan L, Sharifnia P, Armontrout J. Complex Decisional Capacity Assessments: From Disposition, to Organ Donation and Death. APA Annual Meeting May 18th-22nd, 2019.
Andrusiak MG, Sharifnia P, Lyu X, Wang Z, Dickey AM, Wu Z, Chisholm AD, Jin Y. Inhibition of Axon Regeneration by Liquid-like TIAR-2 Granules. Neuron (2019), 104(2):290-304
Sharifnia P, Kim KW, Wu Z, Jin Y. Distinct cis elements in the 3’UTR of the C. elegans cebp-1 mRNA mediate its regulation in neuronal development. Dev Biol (2017), 429(1):240-248
Sharifnia P and Jin Y. Regulatory roles of RNA binding proteins in the nervous system of C. elegans. Front. Mol. Neurosci (2015), 7 (100). doi: 10.3389/fnmol.2014.00100
Berger M, Scheel DW, Macias H, Miyatsuka T, Kim H, Hoang P, Ku GM, Hoing G, Liou A, Tang Y, Regard JB, Sharifnia P, Yu L, Wang J, Coughlin SR, Conklin BR, Deneris ES, Tecott LH, German MS. Gαi/o-coupled receptor signaling restricts pancreatic β-cell expansion. Proc Natl Acad Sci USA. (2015), 112(9):2888-93
Kurup N*, Sharifnia P*, Jin Y. Spatial and temporal dynamics of neurite regrowth. Current Opin Neurobio. (2013), 23(6):1011-7
Sharifnia P and Jin Y. Identifying regulatory elements mediating axonal mRNA stability and translation. Society of Neuroscience Annual Conference. November 9-13 2013. San Diego, CA